Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Geoffrey M, Boxer"'
Autor:
Vessela, Vassileva, Vineeth, Rajkumar, Mario, Mazzantini, Mathew, Robson, Adam, Badar, Surinder, Sharma, Erik, Årstad, Daniel, Hochhauser, Mark F, Lythgoe, Jane, Kinghorn, Geoffrey M, Boxer, Rosmund Barbara, Pedley
Publikováno v:
Journal of Nuclear Medicine. 56:1239-1245
Despite extensive efforts to improve the clinical management of patients with colorectal cancer, approved treatments for advanced disease offer limited survival benefit. Therefore, the identification of novel treatment strategies is essential. We eva
Autor:
Allan B. MacLean, Richard H. J. Begent, Geoffrey M. Boxer, K. Elmasry, Richard W Morris, G K Siddiqui, M Rashid, A Wong te Fong
Publikováno v:
Angiogenesis. 14:155-161
For patients with epithelial ovarian cancer (EOC) cytoreduction, with a combination of taxane and platinum, is the standard of care. Despite this, approximately 50% of patients with advanced disease will relapse and moreover 15-20% of cases of EOC ar
Autor:
Vineeth Rajkumar, Geoffrey M. Boxer, Gary Cook, Mathew Robson, Vicky Goh, Musib Siddique, RB Pedley
Publikováno v:
Rajkumar, V, Goh, V J-L, Siddique, M M, Robson, M, Boxer, G, Pedley, R B & Cook, G J R 2015, ' Texture analysis of (125)I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response. ', BJC: British Journal of Cancer, vol. 112, pp. 1882-1887 . https://doi.org/10.1038/bjc.2015.166
British Journal of Cancer
British Journal of Cancer
Background: We aimed to test the ability of texture analysis to differentiate the spatial heterogeneity of 125I-A5B7 anti-carcinoembryonic antigen antibody distribution by nano-single photon emission computed tomography (SPECT) in well-differentiated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76ded54fe2df5903859214c2f67382d
https://kclpure.kcl.ac.uk/en/publications/1729c1a7-5f44-4ed1-a42d-a820c91d6b19
https://kclpure.kcl.ac.uk/en/publications/1729c1a7-5f44-4ed1-a42d-a820c91d6b19
Autor:
Surinder K. Sharma, R. Barbara Pedley, Jeetendra Bhatia, Geoffrey M. Boxer, Ethaar El-Emir, Uzma Qureshi, Berend Tolner, Helen Lowe, N. Paul Michael, Nigel Minton, Richard H. J. Begent, Kerry A. Chester
Publikováno v:
Clinical Cancer Research. 11:814-825
Purpose: Antibody-directed enzyme prodrug therapy (ADEPT) requires highly selective antibody-mediated delivery of enzyme to tumor. MFE-CP, a multifunctional genetic fusion protein of antibody and enzyme, was designed to achieve this by two mechanisms
Autor:
Geoffrey M. Boxer, Ethaar El-Emir, Jason L. J. Dearling, A J Green, Aiden A. Flynn, Robert Boden, Richard H. J. Begent, R. Barbara Pedley
Publikováno v:
Radiation Research. 159:182-189
The therapeutic efficacy of radiolabeled antibody fragments can be limited by nephrotoxicity, particularly when the kidney is the major route of extraction from the circulation. Conventional dose estimates in kidney assume uniform dose deposition, bu
Autor:
James A. Raleigh, Ethaar El-Emir, Geoffrey M. Boxer, Aiden A. Flynn, Sally A. Hill, Jason L. J. Dearling, Richard H. J. Begent, R. Barbara Pedley, Reeya Motha, Sam Stuart
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:1524-1531
Purpose: Tumor heterogeneity necessitates the use of combined therapies. We have shown that combining antibody-directed therapy with antivascular agents converts a subcurative to a curative treatment. The purpose of this study was to investigate, by
Autor:
Richard H. J. Begent, RB Pedley, J Bhatia, A J Green, AA Flynn, R Boden, Geoffrey M. Boxer, Richard W Morris
Publikováno v:
International Journal of Radiation Biology. 78:407-415
Estimating the absorbed dose to tumour relative to normal tissues has often been used in the assessment of the therapeutic efficacy of radiolabelled antibodies for radioimmunotherapy. Typically, the calculations assume a uniform dose deposition and r
Publikováno v:
Radiation Research. 156:28-35
Flynn, A. A., Green, A. J., Pedley, R. B., Boxer, G. M., Boden, R. and Begent, R. H. J. A Mouse Model for Calculating the Absorbed Beta-Particle Dose from (131)I- and (90)Y-Labeled Immunoconjugates, Including a Method for Dealing with Heterogeneity i
Publikováno v:
Cancer Immunology, Immunotherapy. 50:77-81
Antibody-directed cancer therapy has achieved encouraging responses despite poor localisation in tumour. This discrepancy may be attributed to heterogeneity of antibody delivery within tumours: preferential localisation in the better perfused and mor
Autor:
N. P. Michael, Geoffrey M. Boxer, Surinder K. Sharma, D. A. Read, RB Pedley, KA Chester, J Bhatia, Richard H. J. Begent, R Boden
Publikováno v:
International Journal of Cancer. 85:571-577
Antibody-directed enzyme prodrug therapy (ADEPT) targets an enzyme selectively to a tumor where it converts a relatively non-toxic prodrug to a potent cytotoxic drug. Previous clinical work using antibody-enzyme chemical conjugates has been limited b